Amneal Pharmaceuticals, Inc. — All Filings
642 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
15-12G
25
25-NSE
3
4
4/A
424B3
424B7
5
8-A12B
8-K
8-K/A
8-K12B
CERT
CORRESP
DEF 14A
DEF 14C
DEFA14A
EFFECT
POS AM
POSASR
PRE 14A
PRE 14C
RW
S-1
S-1/A
S-3ASR
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0002007317-25-000849 | Aug 12, 2025 | — |
| SCHEDULE 13D/A | — | 0000898432-25-000584 | Aug 8, 2025 | — |
| 10-Q | 10-Q | 0001723128-25-000047 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K/A | 8-K/A | 0001723128-25-000040 | Aug 5, 2025 | — |
| 8-K | 8-K | 0001723128-25-000037 | Aug 5, 2025 | — |
| 8-K | FORM 8-K | 0000950103-25-009701 | Aug 1, 2025 | — |
| 8-K | FORM 8-K | 0000950103-25-009253 | Jul 24, 2025 | — |
| 8-K | FORM 8-K | 0000950103-25-009025 | Jul 21, 2025 | — |
| 8-K | 8-K | 0001723128-25-000033 | Jul 21, 2025 | Jul 16, 2025 |
| 4 | FORM 4 | 0001628280-25-032108 | Jun 18, 2025 | Jun 16, 2025 |
| 4 | FORM 4 | 0001628280-25-030958 | Jun 12, 2025 | Jun 10, 2025 |
| 4 | FORM 4 | 0001628280-25-026513 | May 19, 2025 | May 16, 2025 |
| 144 | — | 0002007317-25-000405 | May 16, 2025 | — |
| SCHEDULE 13G/A | — | 0000898432-25-000342 | May 14, 2025 | — |
| 4 | FORM 4 | 0001628280-25-025140 | May 13, 2025 | May 12, 2025 |
| 144 | — | 0002007317-25-000348 | May 12, 2025 | — |
| 4 | FORM 4 | 0001628280-25-023998 | May 8, 2025 | May 5, 2025 |
| 8-K | 8-K | 0001723128-25-000024 | May 8, 2025 | — |
| 4 | FORM 4 | 0001628280-25-024000 | May 8, 2025 | May 5, 2025 |
| 4 | FORM 4 | 0001628280-25-023966 | May 8, 2025 | May 5, 2025 |
| 4 | FORM 4 | 0001628280-25-023985 | May 8, 2025 | May 5, 2025 |
| 4 | FORM 4 | 0001628280-25-023987 | May 8, 2025 | May 5, 2025 |
| 4 | FORM 4 | 0001628280-25-024004 | May 8, 2025 | May 5, 2025 |
| 4 | FORM 4 | 0001628280-25-023991 | May 8, 2025 | May 5, 2025 |
| 4 | FORM 4 | 0001628280-25-023993 | May 8, 2025 | May 5, 2025 |
| 4 | FORM 4 | 0001628280-25-023989 | May 8, 2025 | May 5, 2025 |
| 10-Q | 10-Q | 0001723128-25-000022 | May 7, 2025 | Mar 31, 2025 |
| 4 | FORM 4 | 0001628280-25-022719 | May 6, 2025 | May 2, 2025 |
| 144 | — | 0001968582-25-000308 | May 2, 2025 | — |
| 8-K | 8-K | 0001723128-25-000018 | May 2, 2025 | — |
| SCHEDULE 13G | — | 0000932471-25-000656 | Apr 30, 2025 | — |
| 4 | FORM 4 | 0001628280-25-016184 | Apr 2, 2025 | Apr 1, 2025 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001308179-25-000220 | Mar 25, 2025 | May 6, 2025 |
| DEFA14A | DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS | 0001308179-25-000221 | Mar 25, 2025 | — |
| 4 | — | 0000898432-25-000191 | Mar 17, 2025 | Mar 14, 2025 |
| SCHEDULE 13D/A | — | 0000898432-25-000189 | Mar 17, 2025 | — |
| 144 | — | 0001971522-25-000003 | Mar 14, 2025 | — |
| 4 | FORM 4 | 0001628280-25-012344 | Mar 12, 2025 | Mar 10, 2025 |
| 4 | FORM 4 | 0001628280-25-011300 | Mar 7, 2025 | Mar 5, 2025 |
| 4 | FORM 4 | 0001628280-25-011303 | Mar 7, 2025 | Mar 5, 2025 |
| 4 | FORM 4 | 0001628280-25-011306 | Mar 7, 2025 | Mar 5, 2025 |
| 4 | FORM 4 | 0001628280-25-011310 | Mar 7, 2025 | Mar 5, 2025 |
| 8-K | 8-K | 0001723128-25-000014 | Mar 6, 2025 | Mar 1, 2025 |
| 4 | FORM 4 | 0001628280-25-010678 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | FORM 4 | 0001628280-25-010679 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | FORM 4 | 0001628280-25-010688 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | FORM 4 | 0001628280-25-010693 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | FORM 4 | 0001628280-25-010713 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | FORM 4 | 0001628280-25-010718 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | FORM 4 | 0001628280-25-010719 | Mar 5, 2025 | Mar 3, 2025 |